Background The metabolic basis of Alzheimer disease (AD) pathology and expression of AD
symptoms is poorly understood. Omega-3 and -6 fatty acids have previously been linked to …

Psoriasis is an immune-mediated highly heterogeneous skin disease in which genetic as
well as environmental factors play important roles. In spite of the local manifestations of the …

Lipids such as ceramides and phosphatidylcholines (PC) have been found altered in the
plasma of Alzheimer’s disease (AD) patients in a number of discovery studies. For this reason, …

Background Both serotonergic signalling disruption and systemic inflammation have been
associated with the pathogenesis of Alzheimer’s disease (AD). The common denominator …

Background: Cholinesterase inhibitors represent three of the four treatments for Alzheimer’s
disease (AD), and target the pathological reduction of acetylcholine levels. Here we aimed …

Background and Objective: Aberrant lipid metabolism has been implicated in sporadic
Alzheimer’s disease (AD). The current study investigated plasma phospholipid and sphingolipid …

Alzheimer’s disease (AD) is the most common neurodegenerative dementia, with the
accumulation of extracellular amyloid-β and formation of neurofibrillary tau tangles as leading …

Genome‐wide association studies in adults have identified variants in hydroxysteroid 17‐beta
dehydrogenase 13 (HSD17B13) and mitochondrial amidoxime reducing component 1 (…

Introduction This study was motivated by the report that infant development correlates with
particular lipids in infant plasma. Objective The hypothesis was that the abundance of these …

Unbiased metabolomic analysis of biological samples is a powerful and increasingly commonly
utilised tool, especially for the analysis of bio-fluids to identify candidate biomarkers. To …